Entrada Therapeutics
TRDA
#7194
Rank
NZ$0.69 B
Marketcap
$18.56
Share price
2.77%
Change (1 day)
-11.62%
Change (1 year)

EPS for Entrada Therapeutics (TRDA)

EPS in 2023 (TTM): -$4.26

According to Entrada Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.45. In 2022 the company made an earnings per share (EPS) of -$5.21 a decrease over its 2021 EPS that were of -$3.96.

EPS history for Entrada Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.26-18.32%
2022-$5.2131.74%
2021-$3.96